Motives and predictors of modified Atkins diet discontinuation as treatment of adults with drug‐resistant epilepsy
Epilepsia · 2026-01 · 67 (1) · 199-212
DOI: 10.1111/epi.18657 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Epilepsia, online erschienen am 03.10.2025. Verfasst von Raquel Samões und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, Centro Hospitalar Universitário de Santo António, Unidade Local de Saúde (ULS) de Santo António, Porto, Portugal. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Motivation, Diet, High-Protein Low-Carbohydrate, Patient Compliance. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tecnifar, Centro Hospitalar Universitário do Porto, Liga Portuguesa contra a Epilepsia.
Abstract (Originalsprache)
Objective
This study was undertaken to explore the motives and predictors of modified Atkins diet (MAD) discontinuation as a treatment of adults with drug‐resistant epilepsy (DRE).
Methods
A single‐center observational longitudinal study was made of a cohort of patients treated with MAD during the first 6 years at a multidisciplinary outpatient clinic dedicated to adult patients. Time to MAD discontinuation analyses were used to explore sociodemographic, clinical, and biochemical predictors of MAD persistence.
Results
Eighty patients initiated MAD (54% females, median age = 29 years, median epilepsy duration = 21 years, median baseline seizure frequency = 30/month, median antiseizure medications = 4, 68% focal epilepsy, 64% structural etiology, and 26% genetic cause). The patients used the diet for a median time of 122 days. Fifteen percent of patients were very early dropouts (before 30 days), 20% were early dropouts (30–89 days), and 17.5% were late dropouts (>365 days). The motives for dropout ( n = 64) were noncompliance (34.4%), inefficacy (23.4%), side effects (23.4%), and diet tiredness (18.8%). Female sex (adjusted hazard ratio [HR] = 1.75, p = .042), focal seizures with preserved consciousness (adjusted HR = 2.69, p = .017), higher glycemic level at baseline (adjusted HR = 1.03, p = .044), and lower level of serum total proteins at baseline (adjusted HR = .55, p = .052) were associated with shorter persistence on MAD. The HR for discontinuation was also higher for patients without daily seizures (HR = 1.72, p = .038). Among patients with at least 3 months in MAD ( n = 51), reduced clinical response at month 3 was associated with earlier discontinuation of MAD, as measured by lower percent seizure reduction (HR = .98, p = .004) and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neurology Department, Centro Hospitalar Universitário de Santo António, Unidade Local de Saúde (ULS) de Santo António, Porto, Portugal.
- Unit for Multidisciplinary Research in Biomedicine, Abel Salazar Biomedical Sciences Institute-University of Porto, Porto, Portugal.
- Laboratory for Integrative and Translational Research in Population Health, Porto, Portugal.
- Nutrition Service, Centro Hospitalar Universitário do Porto, ULS Santo António, Porto, Portugal.
- Immunogenetics Laboratory, Abel Salazar Biomedical Sciences Institute-University of Porto, Porto, Portugal.
- Neuropsychology Service, Centro Hospitalar Universitário de Santo António, ULS Santo António, Porto, Portugal.
ORCID-Profile: Raquel Samões, Bárbara Leal, João Chaves, Sara Cavaco
Förderung
- Tecnifar
- Centro Hospitalar Universitário do Porto
- Liga Portuguesa contra a Epilepsia
- Fundação para a Ciência e a Tecnologia
- ITR - Laboratory for Integrative and Translational Research in Population Health
Zitieren
APA
Samões, R., Cavalheiro, A., Tavares, M. M., Teixeira, C., Leal, B., Chaves, J., & Cavaco, S. (2026). Motives and predictors of modified Atkins diet discontinuation as treatment of adults with drug‐resistant epilepsy. Epilepsia, 67(1), 199-212. https://doi.org/10.1111/epi.18657
Vancouver
Samões R, Cavalheiro A, Tavares MM, Teixeira C, Leal B, Chaves J, et al. Motives and predictors of modified Atkins diet discontinuation as treatment of adults with drug‐resistant epilepsy. Epilepsia. 2026;67(1):199-212. doi:10.1111/epi.18657
BibTeX
@article{Sames2026,
author = {Samões, Raquel and Cavalheiro, Ana and Tavares, Maria Manuel and Teixeira, Catarina and Leal, Bárbara and Chaves, João and Cavaco, Sara},
title = {Motives and predictors of modified Atkins diet discontinuation as treatment of adults with drug‐resistant epilepsy},
journal = {Epilepsia},
year = {2026},
volume = {67},
number = {1},
pages = {199--212},
doi = {10.1111/epi.18657}
}
EUVIMED